B02BD08 • eptacog alpha activated • Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Eptacog alfa activated is a medication used to control and prevent bleeding in patients with hemophilia A or B with inhibitors, as well as in other rare coagulation disorders. It works by stimulating the formation of blood clots, helping to quickly stop bleeding.
It is administered intravenously under strict medical supervision, with the dose adjusted according to the severity of the bleeding and the patient's response.
Side effects may include injection site reactions, fever, headaches, increased risk of thrombosis, or, rarely, severe allergic reactions. Careful monitoring is necessary throughout the treatment.
Eptacog alfa activated is an essential option for patients with coagulation disorders, offering the chance to effectively control bleeding episodes and prevent serious complications.
Substance: eptacog alpha activated
Date of last drug list: 01-07-2013
Commercial code: W52382001
Concentration: 120KUI
Pharmaceutical form: powder + solution for injection
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).